Optic nerve sheath decompression for XXXX cerebri.

@entity1 @entity227 @entity82 @entity6437 @entity2300 @entity260 @entity1781 @entity892 @entity3990
We studied @entity1781 decompressions for @entity6437 cerebri performed at the Kresge Eye Institute, Detroit, over the past year. Six @entity1 (ten eyes) were operated on. Visual function improved in all ten eyes. A decision to operate was based on progressive @entity227 or visual field unresponsive to medical therapy, accompanied by echographic evidence of a distended @entity1781 (positive 30 degrees test). Follow-up ranged from four to 11 months. Four @entity1 underwent subarachnoid @entity3990 (Isovue) contrast injection followed by orbital computed tomography. The subarachnoid space totally filled in all @entity1 . No evidence of @entity82 or obstruction of the @entity1781 existed; however, leakage of dye from the @entity1781 could not be demonstrated. @entity260 included transient @entity892 and transient @entity2300 (one @entity1 each). Our results indicate that @entity1781 decompression improves and protects visual function in @entity1 with @entity6437 cerebri who demonstrate progressive @entity227 and fluid in the @entity1781 .
